“…On the one hand, given the known anti-inflammatory effects of heparin, it has been proposed that heparin released from degranulating mast cells during the allergic asthmatic response functions to limit the extent of subsequent inflammation in response to the initial stimulus, and that inhibition of mast cell degranulation by drugs such as b-adrenoceptor agonists may thus impair this protective function (Page, 1991). By contrast, others have suggested that heparin from mast cells may contribute to allergic inflammation, because heparin proteoglycans, isolated from a murine mastocytoma line (Brunnée et al, 1997) and from human lung (Noga et al, 1999), were found to initiate the contact system via FXII activation. This group (Brunnee et al 1997;Nogi et al 1999) suggested that in allergic reactions mast cellderived heparin can act as a suitable surface to promote this cascade and can contribute to the generation of kinins to participate in the allergic response.…”